facebook
Subscribe50$/product give away!


Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

ASCOR- ascorbic acid injection


  1. Patient Information
  2. Manufactured By:

Patient Information 

  • Inform patients that treatment with ASCOR may increase their risk of oxalate nephropathy[see Warnings and Precautions(5.1)].
  • Inform patients that treatment with ASCOR may impact laboratory results, including blood and urine glucose tests, up to 24 hours after infusion[see Warnings and Precautions(5.3)].
  • Inform patients with glucose-6-phosphate dehydrogenase deficiency that treatment with ASCOR may increase their risk of hemolysis[see Warnings and Precautions(5.2)].

Manufactured By: 

McGuff Pharmaceuticals, Inc., Santa Ana, CA 92704

M381-0073



Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources
2017 © Copyright PharmacyHQ.com. Questions?
Please contact: pharmacyhq.mail@gmail.com